Nylim GBL Ety R&D LDR ETF-UiWRNDETF

13F holders, Q3 2024 (September 30)
4holders
0new positions
0sold out
$30.49avg. 13F price*

At the end of Q3 2024, 4 institutions reported holding Nylim GBL Ety R&D LDR ETF-Ui (WRND) in their 13F filings, unchanged from Q2 2024. 0 opened new positions and 0 sold out. The largest holders were New York Life Investment Management LLC ($5.8M), GTS Securities LLC ($669K) and UBS Group AG ($5K).

Company
Nylim GBL Ety R&D LDR ETF-Ui
Filed as
NEW YORK LIFE INVESTMENTS ET (Q3 2024)
CUSIP
45409B255
Latest filing quarter
Q2 2026

History

Number of 13F holders

012345 Q1 2024: 4Q1 2024Q2 2024: 4Q2 2024Q3 2024: 4Q3 2024Q4 2024: 4Q4 2024Q1 2025: 3Q1 2025Q2 2025: 3Q2 2025Q3 2025: 3Q3 2025Q4 2025: 1Q4 2025Q1 2026: 4Q1 2026Q2 2026: 5Q2 2026

Total Exit/New Position Q2 2024 → Q3 2024

InstitutionsTotal Value
New Positions0$0
Exits0$0

All 13F filers, Q2 2024 → Q3 2024: 3,285 shares bought, net +3,285 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 4 holders

New York Life Investment Management LLC 0.06% No change 190,000 $5.8M
GTS Securities LLC 0.01% Add +16.9% 22,100 $669K
UBS Group AG 0.00% Add +128.6% 160 $5K
Tower Research Capital LLC (TRC) 0.00% No change 11 $333

"% of holder's portfolio" is WRND's weight in each manager's 13F, not the share of Nylim GBL Ety R&D LDR ETF-Ui the manager owns.